Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

An elderly man with serious medical issues has been reported missing on Houston’s northside. Judas Edmond, 79, was last seen ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Montana State University Extension has released volume two of a magazine on Alzheimer’s disease and related dementias. The ...

Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

UW-Madison said reductions in NIH funding will "ultimately harm the livelihoods of real people across Wisconsin and the ...